Effect of a 'Rapid-Return-to-work Program' in Mild Mental Disorders.

June 30, 2020 updated by: Aage Indahl, The Hospital of Vestfold

Effect of a 'Rapid-Return-to-work Program' in Mild Mental Disorders. A Randomized Controlled Trial.

This study is a pragmatic randomized controlled trial (RCT) evaluating the effect of brief versus short psychotherapy in subjects with substantial mental complaints.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Running evaluations of the brief intervention (BI) at our outpatient clinic preceding to this study had given us the impression that the patients obtained a more active coping style towards their health problems with consequential enhanced work participation (WP). These evaluations, in addition to our experiences in BI for low back pain (LBP) has generated the current hypothesis of this study towards WP. Yet, the sustainability of WP and long-term effects on mental health remained questionable. In this pragmatic RCT the objective was to compare brief psychotherapy with focus on normalization and coping (Brief-PsT) with short-term psychotherapy of standard duration with more extended focus (Short-PsT), as otherwise used at the Mental Health services. The primary aim of this study was to assess differences in effect on WP and the secondary aim was to assess differences in clinical response. The investigators hypothesized that in the short term, Brief-PsT could facilitate or sustain WP in a superior fashion to Short-PsT in persons who are on, or at risk of sick leave due to mental health problems. Although the investigators expected a substantial long-term rate of clinical recovery and reduction in mental health-related symptoms in both groups, the investigators had no specific hypothesis regarding the extent and direction of possible group differences in these clinical measurements.

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 67 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 'mental complaints' was the main reason for referral to the outpatient clinic
  • employed and on or at risk of sick leave

Exclusion Criteria:

  • acute or severe pathology that required greater input than the clinic could offer,
  • Sick-leave had > 9 months during the preceding 2 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brief psychotherapy (brief PsT)
The focus was on normalizing, accepting and coping with their present mental health complaints and their hindrance for work participation. Primarily, there was no intention to process previous pathogenic experiences. The standard duration was set on six sessions.
Active Comparator: Short psychotherapy (short-PsT)
With more extended focus, there was besides coping of mental health and challenges concerning WP, an emphasis on both an extensive anamnesis and possibility to establish a so-called central theme based on previous or current challenging issues such as trauma, difficult childhood conditions, and personality-related issues. Additional aims of the intervention could include reducing symptoms and problematic behaviour and an improvement of home situation, with deeper focus on cognitive maladaptive coping strategies or dynamic repetitions. The number of sessions was aimed to be 20 on average

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Return to Work (RTW) to 3 months follow-up
Time Frame: baseline - 3 months
Transitions from baseline to 3 months follow-up in Work Participation degree
baseline - 3 months
Change in Return to Work (RTW) to 1 year follow-up
Time Frame: baseline - 1 year
Transitions from baseline to 1 year follow-up in Work Participation degree
baseline - 1 year
Change in Return to Work (RTW) to 2 year follow-up
Time Frame: baseline - 2 year
Transitions from baseline to 2 year follow-up in Work Participation degree
baseline - 2 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical recovery
Time Frame: 2 years
A minimal score on both Beck Inventories (BDI ≤ 13 and BAI ≤ 9)
2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Index - II (BDI)
Time Frame: baseline, 2 year follow-up
Score 0-63, higher scores mean worse outcome
baseline, 2 year follow-up
Beck Anxiety Index (BAI)
Time Frame: baseline, 2 year follow-up
Score 0-63, higher scores mean worse outcome
baseline, 2 year follow-up
Hopkins Symptoms Checklist-10
Time Frame: baseline, 2 year follow-up
Score 1-4, higher scores mean worse outcome
baseline, 2 year follow-up
Subjective health complaints (SHC)
Time Frame: baseline, 2 year follow-up
Score 0-29, higher scores mean worse outcome
baseline, 2 year follow-up
Self-efficacy (GSES)
Time Frame: baseline - 2 year follow-up
Score 1-4 , lower scores means worse outcome
baseline - 2 year follow-up
Lfe satisfaction (LISAT)
Time Frame: baseline - 2 year follow-up
Score 1-6, lower scores means worse outcome
baseline - 2 year follow-up
Illness perception (bIPC)
Time Frame: baseline - 2 year follow-up
Score 1-10, higher scores mean worse outcome
baseline - 2 year follow-up
Fear avoidance beliefs -work (FABQ-work)
Time Frame: baseline - 2 year follow-up
Score 0-7, higher scores mean worse outcome
baseline - 2 year follow-up
Global Perceived Effect
Time Frame: 2 year follow-up
Score 0-7, lower scores means worse outcome
2 year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Aage Indahl, Prof.Dr, Vestfol Hospital Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2013

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

June 26, 2020

First Submitted That Met QC Criteria

June 30, 2020

First Posted (Actual)

July 7, 2020

Study Record Updates

Last Update Posted (Actual)

July 7, 2020

Last Update Submitted That Met QC Criteria

June 30, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Disorder

Clinical Trials on Psychotherapy

3
Subscribe